Tiziana life sciences announces appointment of william a. clementi as chief development officer

New york, aug. 23, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa ) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, is pleased to announce that it has appointed william a. clementi, pharm.d., fcp as chief development officer. dr. clementi will formally take up the cdo role effective september 1, 2023. in this role, dr. clementi will be responsible for overseeing the company's development strategies and advancing its portfolio of groundbreaking therapeutic candidates.
TLSA Ratings Summary
TLSA Quant Ranking